Authors : Shahin Shaik; Namoju Rasagnya; Sridevi

Volume/Issue : Volume 11 - 2026, Issue 8 - August

Google Scholar : https://tinyurl.com/3s37usts

Scribd : https://tinyurl.com/2s7y3wvn

DOI : https://doi.org/10.38124/ijisrt/26aug435

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Microneedles are a game-changer when it comes to drug delivery. They can bypass the liver's first-pass metabolism, which means the drug can be more effective and easier to administer. The way the skin is structured, with its different layers like the epidermis, dermis, and hypodermis, plays a big role in how well microneedles work. To make sure the process is painless, these tiny needles are designed to pierce just the outer layer of skin, called the stratum corneum, without triggering any pain receptors. This is important because it allows for controlled drug release, which can be a major advantage in treating various conditions. By simplifying the administration process, microneedles can make a big difference in people's lives.However, there are some downsides to consider - for instance, it can sometimes cause a bit of skin irritation, and making it can be tricky. Also, it has limited space for carrying drugs. Micro needles come in different types, like solid, hollow, dissolvable, swellable, and coated, each with its own unique features and uses. For instance, dissolvable micro needles are designed to safely break down after they're applied, which is really useful. On the other hand, swellable micro needles are great for releasing drugs over a longer period of time. Solid micro needles work by creating tiny channels in the skin, while hollow micro needles are used to deliver liquid medications directly into the body. Then there are coated micro needles, which have drugs attached to their surface, allowing for a more targeted delivery. Each type of micro needle has its own advantages, and they can be used in different ways to achieve specific goals, like improving drug delivery or reducing side effects. Metals, silicon, ceramics, and polymers are among the many materials used in fabrication; polymers are favored because of their mechanical strength, biocompatibility, and biodegradability. In order to promote drug diffusion into systemic circulation, the mechanism of action entails a brief disruption of the skin barrier. Dissolvable micro needle patches can be thrown away as non-sharp waste; proper patch disposal is essential for safety. Applications for micro needles are numerous and include the treatment of migraines, diabetes, cancer, hepatitis B vaccination, ocular drug delivery, and cosmetic procedures. Overall, microneedle systems represent a flexible transdermal platform with increasing relevance for future drug delivery applications.

Keywords : Microneedle Patches, Drug Delivery, Dissolvable Microneedles, Patch Disposal, Ocular Delivery.

References :

1. Giudice EL, Campbell JD Needle-free vaccine delivery. Adv Drug Del Rev. 2006;58:68–89. doi: 10.1016/j.addr.2005.12.003.
2. Nir Y, Paz A, Sabo E, Potasman I. Fear of injections in young adults: Prevalence and associations. Am J Trop Med Hyg. 2003;68:341–344.
3. Hamilton JG. Needle phobia - a neglected diagnosis. J Fam Pract. 1995;41:169–175.
4. Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358:1989–1992. doi: 10.1016/S0140-6736(01)06967-7.
5. Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004;19:95–103. doi: 10.1093/heapro/dah110.
6. Singh R, Singh S, Lillard JW. Past, present, and future technologies for oral delivery of therapeutic proteins.J Pharm Sci. 2008;97:2497–2523. doi: 10.1002/jps.21183.
7. Amorij JP, Hinrichs WLJ, Frijlink HW, Wilschut JC, Huckriede A. Needle-free influenza vaccination. Lancet Infect Dis. 2010;10:699–711. doi: 10.1016/S1473-3099(10)70157-2.
8. Mitragotri S. Immunization without needles. Nat Rev Immunol. 2005;5:905–916. doi: 10.1038/nri1728.
9. B. Abdul Rasool Hassan, “Overview on Drug Delivery System,” 2012, doi: 10.4172/2153-2435.1000e137.
10. G. Robbie, T. C. Wu, and W. L. Chiou. “Poor and unusually prolonged oral absorption of amphotericin B in rats,” Pharm Res, vol. 16, no. 3, pp. 455–458, 1999, doi: 10.1023/A:1011961322883.
11. A. A. Date and M. S. Nagarsenker “Parenteral microemulsions: an overview,” Int J Pharm, vol. 355, no. 1–2, pp. 19–30, May 2008, doi: 10.1016/J.IJPHARM.2008.01.004.
12. J. L. Rau, “The inhalation of drugs: advantages and problems,” Respir Care, vol. 50, no. 3, pp. 367–382, Mar. 2005, Accessed: Jun. 22, 2024. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/15737247/
13. X. M. Zeng, G. P. Martin, and C. Marriott, “The controlled delivery of drugs to the lung,” Int J Pharm, vol. 124, no. 2, pp. 149–164, Oct. 1995, doi: 10.1016/0378-5173(95)00104-Q.
14. M. H. El-Newehy, M. E. El-Naggar, S. Alotaiby, H. El-Hamshary, M. Moydeen, and S. Al-Deyab, “ Green Electrospining of Hydroxypropyl Cellulose Nanofibres for Drug Delivery Applications,” J Nanosci Nanotechnol, vol. 18, no. 2, pp. 805–814, Sep. 2018, doi: 10.1166/JNN.2018.13852.
15. H. Om et al., “Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes,” Invest New Drugs, vol. 38, no. 5, pp. 1303–1315, Oct. 2020, doi: 10.1007/S10637-020-00905-6.
16. Murphrey MB, Zito PM. Histology, Stratum Corneum. StatPearls. Published online 2018. http://www.ncbi.nlm.nih.gov/pubmed/30020671
17. Chen J, Lu WL, Gu W, Lu SS, Chen ZP, Cai BC. Skin permeation behavior of elastic liposomes: Role of formulation  ingredients. Expert Opin Drug Deliv. 2013;10(6):845-856. https://doi.org/10.1517/17425247.2013.779252 PMid:23550630
18. Geerligs M. Skin layer mechanics.Ski layer Mech. 2010;1(2010):122.
19. Moakes RJA, Senior JJ, Robinson TE, et al. A suspended layer additive manufacturing approach to the bioprinting of tri-layered skin equivalents. APL Bioeng. 2021;5(4). https://doi.org/10.1063/5.0061361 PMid:34888433 PMCid:PMC8635740
20. R. Donnelly and D. Douroumis. “Microneedles for drug and vaccine delivery and patient monitoring,” Drug Deliv Transl Res, vol. 5, no. 4, pp. 311–312, Aug. 2015, doi: 10.1007/S13346-015-0250-2.
21. E. L. Giudice and J. D. Campbell, “Needle-free vaccine delivery,” Adv Drug Deliv Rev, vol. 58, no. 1, pp. 68–89, Apr. 2006, doi: 10.1016/J.ADDR.2005.12.003.
22. A. C. Williams and B. W. Barry, “Penetration enhancers,” Adv Drug Deliv Rev, vol. 56, no. 5, pp. 603–618, Mar. 2004, doi: 10.1016/j.addr.2003.10.025.
23. A. S. Rzhevskiy, T. R. R. Singh, R. F. Donnelly, and Y. G. Anissimov, “Microneedles as the technique of drug delivery enhancement in diverse organs and tissues,” J Control Release, vol. 270, pp. 184–202, Jan. 2018, doi: 10.1016/J.JCONREL.2017.11.048.
24. S. H. Bariya, M. C. Gohel, T. A. Mehta, and O. P. Sharma, “Microneedles: an emerging transdermal drug delivery system,” J Pharm Pharmacol, vol. 64, no. 1, pp. 11–29, Jan. 2012, doi: 10.1111/J.2042-7158.2011.01369.X.
25. D. Ramadon, M. T. C. McCrudden, A. J. Courtenay, and R. F. Donnelly, “Enhancement strategies for transdermal drug delivery systems: current trends and applications,” Drug Deliv Transl Res, vol. 12, no. 4, p. 758, Apr. 2022, doi: 10.1007/S13346-021-00909-6.
26. K. Kawahara and K. Tojo, “Skin irritation in transdermal drug delivery systems: a strategy for its reduction,” Pharm Res, vol. 24, no. 2, pp. 399–408, Feb. 2007, doi: 10.1007/S11095-006-9165-4.
27. J. Li, M. Zeng, H. Shan, C. Tong Microneedle patches as drug and vaccine delivery platform Curr. Med. Chem., 24 (22) (2017), pp. 2413-2422
28. K. Ita Transdermal delivery of drugs with microneedles-potential and challenges Pharmaceutics, 7 (3) (2015), pp. 90-105
29. M.R. Prausnitz Engineering microneedle patches for vaccination and drug delivery to skin Annu. Rev. Chem. Biomol. Eng., 8 (2017), pp. 177-200
30. S.P. Narayanan, S. Raghavan Solid silicon microneedles for drug delivery applications Int. J. Adv. Manuf. Technol., 93 (1-4) October) (2017), pp. 407-422
31. K. Ita Transdermal delivery of drugs with microneedles-potential and challenges Pharmaceutics, 7 (3) (2015), pp. 90-105
32. K. Cheung, T. Han, D.B. Das Effect of force of microneedle insertion on the permeability of insulin in skin J. Diabetes Sci. Technol., 8 (3) (2014), pp. 444-452
33. D. Sharma Microneedles: an Approach in Transdermal Drug Delivery: a Review (2017)
34. E. Larrañeta, R.E.M. Lutton, A.D. Woolfson, R.F. Donnelly Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development
35. X. Hong, L. Wei, F. Wu, Z. Wu, L. Chen, Z. Liu, W. Yuan Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine
36. M.A. Hopcroft, W.D. Nix, T.W. Kenny What is the Young’s Modulus of Silicon? J. Microelectromechanical Syst., 19 (2) (2010), pp. 229-238
37. R.F. Donnelly, T.R. Raj Singh, A.D. Woolfson Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety Drug Deliv., 17 (4) (2010), pp. 187-
38. F.J. Verbaan, S.M. Bal, D.J. van den Berg, W.H. Groenink, H. Verpoorten, R. Luttge, J.A. Bouwstra Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin J. Control. Release, 117 (2) (2007), pp. 238-
39. M. Niinomi, M. Nakai Titanium-Based Biomaterials for Preventing Stress Shielding Between Implant Devices and Bone
40. S. Gorgieva, V. Kokol Biomaterials Applications for Nanomedicine
41. A.C. Williams, B.W. Barry Penetration enhancers Adv. Drug Deliv. Rev., 56 (5) (2004), pp. 603-618
42. S.D. Gittard, R.J. Narayan, C. Jin, A. Ovsianikov, B.N. Chichkov, N.A. Monteiro-Riviere, S. Stafslien, B. Chisholm Pulsed laser deposition of antimicrobial silver coating on ormocer® microneedles Biofabrication, 1 (4) (2009), p. 41001
43. J. Gupta, E.I. Felner, M.R. Prausnitz Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles Diabetes Technol. Ther., 11 (6) (2009), pp. 329-337
44. D.V. McAllister, P.M. Wang, S.P. Davis, J.H. Park, P.J. Canatella, M.G. Allen, M.R. Prausnitz Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies Proc. Natl. Acad. Sci. U.S.A., 100 (24) (2003), pp. 13755-13760
45. K. Lee, C.Y. Lee, H. Jung Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose Biomaterials, 32 (11) (2011), pp. 3134-3140
46. C.J. Martin, C.J. Allender, K.R. Brain, A. Morrissey, J.C. Birchall Low temperature fabrication of biodegradable sugar glass microneedles for transdermal drug delivery applications J. Control. Release, 158 (1) (2012), pp. 93-101
47. T. Miyano, Y. Tobinaga, T. Kanno, Y. Matsuzaki, H. Takeda, M. Wakui, K. Hanada Sugar micro needles as transdermic drug delivery system Biomed. Microdevices, 7 (3) (2005), pp. 185-188
48. F. Pérennès, B. Marmiroli, M. Matteucci, M. Tormen, L. Vaccari, E. Di Fabrizio Sharp Beveled Tip Hollow Microneedle Arrays Fabricated by LIGA and 3D Soft Lithography With Polyvinyl Alcohol
49. S. Aoyagi, H. Izumi, Y. Isono, M. Fukuda, H. Ogawa Laser fabrication of high aspect ratio thin holes on biodegradable polymer and its application to a microneedle Sens. Actuators A Phys., 139 (1) (2007), pp. 293-302
50. J.H. Park, M.G. Allen, M.R. Prausnitz Polymer microneedles for controlled-release drug delivery Pharm. Res., 23 (5) (2006), pp. 1008-1019
51. M. Han, D.H. Hyun, H.H. Park, S.S. Lee, C.H. Kim, C. Kim A novel fabrication process for out-of-plane microneedle sheets of biocompatible polymer J. Micromech. Microeng., 17 (6) (2007), pp. 1184-1191
52. L.Y. Chu, S.O. Choi, M.R. Prausnitz Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs J. Pharm. Sci., 99 (10) (2010), pp. 4228-4238
53. Y.-C. Kim, F.-S. Quan, R.W. Compans, S.-M. Kang, M.R. Prausnitz Formulation of microneedles coated with influenza virus-like particle vaccine AAPS PharmSciTech, 11 (3) (2010), pp. 1193-1201
54. R.F. Donnelly, R. Majithiya, T.R. Singh, D.I. Morrow, M.J. Garland, Y.K. Demir, K. Migalska, E. Ryan, D. Gillen, C.J. Scott, A.D. WoolfsonDesign, optimization and characterization of polymeric microneedle arrays prepared by a  novel laser-based micro-moulding technique. Pharm. Res., 28 (1) (2011), pp. 41-57
55. H. Huang, C. Fu Different Fabrication Methods of Out-of-plane Polymer Hollow Needle Arrays and Their Variations (2007)
56. D. Sharma Microneedles: an Approach in Transdermal Drug Delivery: a Review (2017)
57. N. Akhtar Microneedles: an Innovative Approach to Transdermal Delivery- a Review (2014).
58. Kim, Y.-C.; Park, J.-H.; Prausnitz, M.R. Microneedles for drug and vaccine delivery. Adv. Drug Deliv. Rev. 2012, 64, 1547–1568.
59. Roxhed, N.; Gasser, T.C.; Griss, P.; Holzapfel, G.A.; Stemme, G. Penetration-Enhanced Ultrasharp Microneedles and Prediction on Skin Interaction for Efficient Transdermal Drug Delivery. J. Microelectromec. Syst. 2007, 16, 1429–1440.
60. Liu, S.; Jin, M.-N.; Quan, Y.-S.; Kamiyama, F.; Kusamori, K.; Katsumi, H.; Sakane, T.; Yamamoto, A. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Eur. J. Pharm. Biopharm.     2014, 86, 267–276.
61. Mikszta, J.; Cormier, M.; Andrianov, A. Microneedle-based vaccines. Curr. Top. Microbiol. Immunol. 2009, 333, 369–393.
62. Matriano, J.A.; Cormier, M.; Johnson, J.; Young, W.A.; Buttery, M.; Nyam, K.; Daddona, P.E. Macroflux^® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization. Pharm. Res. 2002, 19, 63–70.
63. Cormier, M.; Johnson, B.; Ameri, M.; Nyam, K.; Libiran, L.; Zhang, D.D.; Daddona, P. Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 2004, 97, 503–511.
64. Ingrole, R.; Gill, H. Microneedle coating methods: A review with a perspective. J. Pharmacol. Exp. Ther. 2019, jpet.119.258707.
65. Pastore MN, Kalia YN, Horstmann M, Roberts MS. 19.  2015. Transdermal patches: history, development and pharmacology. Br. J. Pharmacol. 172:2179–209
66. Donnelly RF, Mooney K, Caffarel-Salvador E, Torrisi BM, Eltayib E, McElnay JC. 14.  2014. Microneedle-mediated minimally invasive patient monitoring. Ther. Drug Monit. 36:10–17
67. Arya J, Prausnitz MR. 11.  2016. Microneedle patches for vaccination in developing countries. J. Control. Release 240:135–41
68. Rapoport AM, Ameri M, Lewis H, et al,.2020. Development of a novel zolmitriptan intracutaneous microneedle system (QtryptaTM) for the acute treatment of migraine. https://doi. org/102217/pmt-2020-0041. 2020;10(6):359-366. doi:10.2217/ PMT—00416
69. Modi P, 2007, Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus. Curr Drug Discov Technol.;4(1):39-47. doi:10.2174/157016307781115476
70. Mansour A, Romani M, Acharya AB, et al,2023,. Drug Delivery Systems in Regenerative Medicine: An Updated Review. Pharmaceutics.;15(2). doi:10.3390/PHARMACEUTICS15020695
71. C. Wang, Y. Ye, G.M. Hochu, H. Sadeghifar, Z. Gu Enhanced Cancer immunotherapy by microneedle patch-assisted delivery of Anti-PD1 antibody Nano Lett., 16 (4) (2016), pp. 2334-2340
72. Y.W. Naguib, A. Kumar, Z. Cui The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil Acta Pharm. Sin. B, 4 (1) (2014), pp. 94-99
73. S. Bhatnagar, P. Kumari, S.P. Pattarabhiran, V.V.K. Venuganti Zein microneedles for localized delivery of chemotherapeutic agents to treat breast Cancer: drug loading, release behavior, and skin permeation studies AAPS PharmSciTech, 19 (4) (2018), pp. 1818-1826
74. Y. Ye, C. Wang, X. Zhang, Q. Hu, Y. Zhang, Q. Liu, D. Wen, J. Milligan, A. Bellotti, L. Huang, G. Dotti, Z. Gu A melanin-mediated cancer immunotherapy patch Sci. Immunol., 2 (17) (2017), p. 5692
75. J.H. Jung, B. Chiang, H.E. Grossniklaus, M.R. Prausnitz Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle J. Control. Release, 277 (2018), pp. 14-22
76. E. Larrañeta, R.E.M. Lutton, A.D. Woolfson, R.F. Donnelly Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development Mater. Sci. Eng. R Rep., 104 (2016), pp. 1-32
77. G. Serrano, P. Almudever, J.M. Serrano, J. Cortijo, C. Faus, M. Reyes, I. Exposito, A. Torrens, F. Millan Microneedling dilates the follicular infundibulum and increases transfollicular absorption of liposomal sepia melanin Clin. Cosmet. Investig. Dermatol., 8 (2015), pp. 313-318
78. Y.H. Mohammed, M. Yamada, L.L. Lin, J.E. Grice, M.S. Roberts, A.P. Raphael, H.A. Benson, T.W. Prow Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin PLoS One, 9 (7) (2014), p. e101956.